Alirocumab: Focus on high CV risk patients and mortality outcomes in Odyssey

VMA English

Overview

Insights from the clinical program of Odessey showing the positive results of CV outcomes on very high risk patients category with significant reduction for the first time in all cause death .

This Class for

  • Clinical Pharmacy
  • Pharmacy
  • Physician
  • Resident / Fellow

Related Classes

Staying on track: Optimizing the lipid-lowering pathway whilst avoiding treatment gaps Video
Staying on track: Optimizing the lipid-lowering pathway whilst avoiding treatment gaps
By Virtual Medical Academy
Not Relted Topics
Read More
How to prevent the Event in People with T2D and ASCVD Video
How to prevent the Event in People with T2D and ASCVD
By Virtual Medical Academy
Not Relted Topics
Read More
Start Learning
  • clock Last Update 01/2026
  • adjust VMA